Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 02/29/24 07:30:16 on US and Canada Markets.
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. ( BABY ) ( BABYF ) ( 0YL.F ) ("Else" or the "Company"), today announced that it will be showcasing its whole-food, plant-based, dairy-free and soy-free kids Read...
WhiteHorse Finance, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Results and Declares Quarterly Distribution of $0.385 Per Share PR Newswire NEW YORK , Feb. 29, 2024 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company")...
ITURAN PRESENTS FOURTH QUARTER & FULL YEAR 2023 RESULTS ITURAN PRESENTS FOURTH QUARTER & FULL YEAR 2023 RESULTS PR Newswire Dividend Policy increased by 60% to $8 million per quarter; Company introduces full year 2024 EBITDA guidance of $90 - 95...
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress PR Newswire – Total Revenue of $146 Million and U.S. XPOVIO® (selinexor) Net Product Revenue of $112 Million for Full Year 2023, Meeting Co...
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi ® (tafasitamab) by its Brazilian affiliate, United Medical Ltda. Minjuvi ® is indicated in...
Fourth Quarter Highlights Net sales of $1.186 billion GAAP loss from continuing operations of $339.0 million, including asset impairments of $145.4 million Non-GAAP adjusted EBITDA of $190.7 million Core segment adjusted EBITDA of $198.9 million* Cash flow generated by ope...
Conference Call on Thursday, March 14, 2024 at 8:30 a.m. ET Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Company will release its fourth quarter and year end 2023...
TROY, Mich., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced the signing of a multi-year cultivation and ex...
On-track to report key clinical data in 2024 from two on-going Phase 2a clinical trials with imdusiran and the Phase 1a/1b clinical trial with AB-101 Plans to initiate a third Phase 2a clinical trial with imdusiran in first half of 2024 Claim Construction for Moderna LNP litigat...
Biomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
0.41%Change Percent:
GPO Plus Inc Company Name:
GPOX Stock Symbol:
OTCMKTS Market: